Aetion President and Co-Founder Discusses RWE in Recent Coronavirus Study

April 30, 2021

Aetion Co-Founder and President Jeremy Rassen discusses the use of real world evidence (RWE) in a recent Science paper. Researchers used the Aetion Evidence Platform to test therapeutic candidates for coronaviruses using RWE analyses. This study serves as a proof-of-principle that RWE and RWE platforms could greatly accelerate the drug development pipeline.

“This study provides a novel example of how RWE can accelerate the clinical research process by assessing molecular insights to help to identify drug repurposing candidates, or to inform development of a new medication by assessing existing drugs with similar mechanisms of action. If other researchers are able to validate these findings over time, they could inform clinical practice and regulatory decision-making for COVID-19 treatment, or use similar methods to support research in other disease areas.” Read more here.

(Source: Jeremy Rassen, Aetion, 4/8/21)

Share This Story!